Evaluation of HIV-1 drug resistance in newly diagnosed individuals in Italy over the period 2017–2023

20250 citationsJournal Articlegold Open Access

Authors

A C Ka'e · Centre International De Reference Chantal Biya

F Bassani · Azienda Ospedaliera Ospedale Civile di Legnano

O El Khalili · University of Rome Tor Vergata

Antonia Bezenchek · Informa (Italy)

Federica Carli · Ospedale di Parma

A Pupo · Sapienza University of Rome

E Gentilini Cacciola

Abstract

Over the period 2017-2023, the HIV-1 TDR appeared generally stable in Italy. However, the increased prevalence of major TDR in 2023 confirms the importance of continuous TDR surveillance in newly diagnosed individuals to inform clinical practice.

Topics & Keywords

HIV/AIDS drug development and treatment HIV-related health complications and treatments HIV Research and Treatment

Publication Details

Published in: Journal of Global Antimicrobial Resistance

Volume 46, pp. 38-45

DOI: 10.1016/j.jgar.2025.11.003

Field-Weighted Citation Impact: 0.00

Command Palette

Evaluation of HIV-1 drug resistance in newly diagnosed individuals in Italy over the period 2017–2023

Authors

Abstract

Topics & Keywords

Publication Details